Table 3.
Multivariate Analysis of Independent Predictors of SAO and EPS
| Parameters | aOR (95% CI) | P-value |
|---|---|---|
| Predictors of SAO | ||
| Location: parietal lobe | 2.13 (1.37–3.33) | .001 |
| Age, years | 0.98 (0.97–0.99) | .009 |
| KPS score, % | 1.02 (1.01–1.04) | .002 |
| IHC: GFAP ≥35% | 2.07 (1.02–4.20) | .045 |
| Blood test: Chloride >102 U/L | 1.68 (1.18–2.39) | .004 |
| Blood test: Calcium >2.35 mmol/L | 1.29 (0.87–1.93) | .206 |
| Predictors of EPS | ||
| Location: frontal/temporal lobe | 2.34 (1.20–4.56) | .013 |
| Comorbidity: Arterial hypertension | 1.52 (0.86–2.68) | .154 |
| Comorbidity: Second malignancy | 1.62 (0.85–3.07) | .144 |
| Blood test: Hemoglobin <12 g/dL | 2.32 (1.02–5.24) | .044 |
| Blood test: GGT >55 U/L | 1.94 (1.09–3.47) | .025 |
| Blood test: CRP >1.0 mg/dL | 2.45 (1.07–5.58) | .036 |
aOR, adjusted odds ratio; CRP, C-reactive protein; IHC, immunohistochemistry; GFAP, glial fibrillary acidic protein staining percentage; GGT, gamma-glutamyl-transferase. Differences with a P ≤ .05 were regarded as statistically significant.